Click it and Unblock the Notifications
Latest Updates
-
Mamitha Baiju Scores Hat-Trick With ₹200-Crore Hits In A Year: 5 Times Premalu Star Served Effortless Fashion -
Waking Up Multiple Times to Urinate? Doctor Explains When Nighttime Bathroom Trips Need Medical Attention -
Could Your Daily Soft Drink Be Affecting Your Liver? What Doctors Want Regular Consumers To Know -
Vaastu Tips For Children’s Bedroom: From Study Table Placement To Sleep Direction, Expert Shares Simple Rules -
Aja Ekadashi 2026: 6th Or 7th September? Know The Correct Date, Vrat Katha, Tithi And Rituals -
PCOS Is Getting Younger: Why More Teenagers Are Being Diagnosed Than Ever Before -
National Nutrition Week 2026: What To Eat To How To Eat — Expert Shares 7 Ayurveda Rules For Mindful Nutrition -
Kareena Kapoor's Power Dressing At ‘Daayra’ Trailer Launch: 6 Bollywood Actresses Who Owned The Blazer Trend -
Dahi Handi 2026: Why Govindas Form Human Pyramids And What The Tradition Really Means -
Teachers Day 2026: 7 Things Students Can Teach Their Teachers In Return
In A New Breakthrough, Mother-Daughter Duo Develops A Vaccine For Alzheimer's Disease
Alzheimer's disease is an irreversible, progressive brain disorder that causes the brain cells to degenerate and die, resulting in a decline in thinking, memory, behavioural and social skills.
According to the Alzheimer's Association, more than 4 million people in India have some form of dementia. It is estimated that at least 44 million people are living with dementia.
New treatments are still under way to stop, slow or prevent Alzheimer's disease and some of them have been unsuccessful.
The brain disorder is caused by the accumulation of plaque deposits in the brain, which eventually becomes toxic to brain cells. These plaque deposits are one of the biggest problems that are coming in the way to finding a cure for Alzheimer's disease because it's impossible to clear out the deposits from the brain tissue.
However, in a very recent breakthrough for Alzheimer's disease, United Neuroscience, a biotech company founded by Dr Chang Yi Wang, a prolific bio-inventor, her daughter Mei Mei Hu, and son-in-law, Louis Reese announced the results of Phase II a clinical trial on UB-311, an Alzheimer's vaccine.
This vaccine contains synthetic versions of amino acid chains that stimulate the antibodies to attack Alzheimer's protein in the blood, without causing any side effects. The antibodies were analysed in some patients and there was an almost 100% response rate.
Researchers believe that the vaccine can delay the onset of Alzheimer's disease by five years.
Currently, the company is working on the next clinical trial of the vaccine and its goal is to create innumerable vaccines that will be used to protect people from chronic illnesses.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.
Continue with Google